D R Goffinet, M A Bagshaw. Show Affiliations »
Abstract
Mesh： See more » AnimalsAntimetabolites, Antineoplastic/therapeutic useBleomycin/therapeutic useBromodeoxycytidine/therapeutic useBromodeoxyuridine/administration & dosageBromodeoxyuridine/therapeutic useBromouracil/therapeutic useCarcinoma, Squamous Cell/radiotherapyDactinomycin/therapeutic useDose-Response Relationship, RadiationFloxuridine/therapeutic useFluorouracil/therapeutic useHead and Neck Neoplasms/radiotherapyHumansHydroxyurea/therapeutic useIdoxuridine/therapeutic useNeoplasms/drug therapyNeoplasms/radiotherapyNeoplasms, Experimental/radiotherapyRadiation-Sensitizing Agents/therapeutic use
Substances： See more » Antimetabolites, AntineoplasticRadiation-Sensitizing AgentsFloxuridineBromodeoxycytidineBleomycinDactinomycinBromouracilBromodeoxyuridineIdoxuridineFluorouracilHydroxyurea
Year: 1974 PMID： 4143475 DOI： 10.1016/s0305-7372(74)80008-3
Source DB: PubMed Journal: Cancer Treat Rev ISSN： 0305-7372 Impact factor: 12.111